US EditionPublished • loading... • Updated
Parexel expands site alliance program to accelerate study start-up and patient enrolment - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Parexel expands site alliance program to accelerate study start-up and patient enrolment - Express Pharma
Parexel, a global clinical research organisation (CRO) providing clinical and consulting solutions to the life sciences industry, announced the expansion of its Site Alliance Program. The program strengthens the company’s global partnerships with clinical research sites and reinforces its engagement with investigative sites worldwide. The Site Alliance Program includes more than 300 sites and 16,000 investigators, aimed at improving the experien…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
